RBOT
Vicarious Surgical Inc.
ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES
Best Orthopedic Devices Stocks 2026 →
Vicarious Surgical (RBOT) Stock: Buy, Sell, or Hold?
$1.92
-0.12 (-5.88%)
▼
5d:
-10.7%
30d:
-7.69%
90d:
-28.62%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (64%)
Quality Score
49/100
Position
FAIR
Forward P/E & Valuation
-0.5x
Next 12M consensus est.
Wall Street Target
$5.00
+160.4% upside
Options IV & Volume
UNKNOWN Vol
UNKNOWN volume confirmation
Support / Resistance
$1.75 / $2.41
Trend: Strong Downtrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
⏸️ WAIT FOR STABILIZATION: RBOT is down 10.7% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
Get Alerted When RBOT Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: RBOT is currently trading at $1.92, which is considered fair based on recent price action.
Technical Outlook: Technically, RBOT is in a strong downtrend. Immediate support is located at $1.75, while resistance sits at $2.41. Short-term momentum is weak, with the stock down 5.9% recently.
Market Sentiment: The stock scores a mixed 45/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $5.00 (+160.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, RBOT is in a strong downtrend. Immediate support is located at $1.75, while resistance sits at $2.41. Short-term momentum is weak, with the stock down 5.9% recently.
Market Sentiment: The stock scores a mixed 45/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $5.00 (+160.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Company Quality Score
49/100
(HOLD)
Volume Confirmation
UNKNOWN
Confidence Score
64.2%
Trading Range & Key Levels
Support Level
$1.75
Resistance Level
$2.41
Current Trend
Strong Downtrend
Technical data as of
Mar 2, 2026
Quantitative Signal Breakdown
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (45/100)
- BEARISH: Downward momentum (-5.9%)
- BULLISH: Trading 160.4% below Wall St target ($5.00)
- WARNING: Composite score 48/100 in the bottom quintile — this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
-0.47
Wall Street Target
$5.00
(+160.4%)
Share RBOT Analysis
Share this live RBOT analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (RBOT)
Bullish
2 Retail Mentions
Reddit / WSB Comments
1
Bearish
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Sep 26, 2026
Daily AI digest
AI Retail Discussion Summary:
A bullish investor on StockTwits expresses confidence in $RBOT's long-term potential, citing the possibility of significant upside.
Key Retail Themes:
long-term investment
upside potential
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 10, 2026 9:36 PM ET
Data refreshes hourly during market hours. Next update: 10:36 PM
Data refreshes hourly during market hours. Next update: 10:36 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is RBOT showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
DXCM
DexCom Inc |
STRONG BUY
29 analysts |
$98 | 47 HOLD |
|
EW
Edwards Lifesciences Corp |
STRONG BUY
30 analysts |
$112 | 42 HOLD |
|
BSX
Boston Scientific Corp |
BUY
31 analysts |
$50 | 53 HOLD |
|
ABT
Abbott Laboratories |
STRONG BUY
28 analysts |
$119 | 37 SELL |
|
SYK
Stryker Corporation |
STRONG BUY
30 analysts |
$340 | 31 SELL |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive RBOT Research Pages
